Harris & Harris Group, Inc.  

(Public, NASDAQ:TINY)   Watch this stock  
Find more results for Richard Harris
2.45
0.00 (0.00%)
Sep 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.41 - 2.50
52 week 2.31 - 3.85
Open 2.42
Vol / Avg. 32,797.00/49,392.00
Mkt cap 76.74M
P/E     -
Div/yield     -
EPS -0.54
Shares 31.32M
Beta 1.38
Inst. own 31%
Aug 13, 2015
Q2 2015 Harris and Harris Group Inc Earnings Call
Aug 10, 2015
Q2 2015 Harris and Harris Group Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -510.47% -2620.78%
Operating margin -550.07% -1526.02%
EBITD margin - -1515.72%
Return on average assets -5.25% -11.44%
Return on average equity -5.83% -11.68%
Employees 12 -
CDP Score - -

Address

24th Floor, 1450 Broadway
NEW YORK, NY 10018
United States - Map
+1-212-5820900 (Phone)
+1-212-5829563 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Harris & Harris Group, Inc. is a venture capital firm. The Firm is regulated as a business development company. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. As a venture capital firm, it invests in and provides managerial assistance to its portfolio companies. The Firm's investment has two characteristics: early stage, where its focus is on founding, incubating and building transformative companies from disruptive science, and BIOLOGY+, investments in interdisciplinary life science companies, where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics.

Officers and directors

Douglas W. Jamison Chairman of the Board, Chief Executive Officer, Managing Director
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel B. Wolfe Ph.D. President, Chief Operating Officer, Managing Director
Age: 38
Bio & Compensation  - Reuters
Patricia N. Egan CPA Chief Financial Officer
Age: 40
Bio & Compensation  - Reuters
Alexei A. Andreev Ph.D. Executive Vice President, Managing Director
Age: 42
Bio & Compensation  - Reuters
Mary P. Brady CPA Vice President, Senior Controller
Age: 53
Bio & Compensation  - Reuters
Blake L. Stevens Vice President, Senior Associate
Age: 32
Bio & Compensation  - Reuters
Misti Ushio Ph.D. Chief Strategy Officer , Managing Director
Age: 43
Bio & Compensation  - Reuters
W. Dillaway Dillaway Ayres Jr. Independent Director
Age: 64
Bio & Compensation  - Reuters
Phillip A. Bauman Independent Director
Age: 59
Bio & Compensation  - Reuters
Stacy R Brandom Independent Director
Age: 57
Bio & Compensation  - Reuters